Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy

Jia Wei(Ministry of Education of the People's Republic of China), Jiayuh Lin(University of Maryland, Baltimore)
Journal of Experimental & Clinical Cancer Research
February 8, 2019
10.1186/s13046-019-1072-8
Cited by 66

Related Papers

Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
|Cancer Research|2010|233
Stat3 activation in human endometrial and cervical cancers
|British Journal of Cancer|2007|164
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
|British Journal of Cancer|2005|150
LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
|British Journal of Cancer|2009|93
New structural analogues of curcumin exhibit potent growth suppressive activity in human colorectal carcinoma cells
|BMC Cancer|2009|87